WCM
Wildcat Capital Management Portfolio holdings
AUM
$168M
This Quarter Return
-5.28%
1 Year Return
-10.74%
3 Year Return
+57.92%
5 Year Return
+2.31%
10 Year Return
+525.89%
AUM
$168M
AUM Growth
+$168M
(-10%)
Cap. Flow
-$5.12M
Cap. Flow
% of AUM
-3.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$4.05M |
| 2 |
KRON
Kronos Bio
KRON
|
$1.07M |
Sector Composition
| 1 | Industrials | 70.36% |
| 2 | Consumer Staples | 23.7% |
| 3 | Healthcare | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Frontier Group Holdings
ULCC
$1.12B
| $102M | 60.52% | 28,061,351 | – | – |
|
2
RLX Technology
RLX
$3.09B
| $39.9M | 23.7% | 18,046,195 | – | – |
|
|
TIC
3
Acuren Corporation
TIC
$2.26B
| $16.6M | 9.84% | 1,500,000 | – | – |
|
4
UroGen Pharma
URGN
$900M
| $6.79M | 4.03% | 495,606 | – | – |
|
5
Allogene Therapeutics
ALLO
$251M
| $3.12M | 1.85% | 2,920,787 | – | – |
|
|
SLXN
6
Silexion Therapeutics Corp Ordinary Shares
SLXN
$5.36M
| $91.9K | 0.05% | 113,428 | – | – |
|
|
CNTA
7
Centessa Pharmaceuticals
CNTA
$2.25B
| – | – | -281,859 | Closed | -$4.05M |
|
|
KRON
8
DELISTED
Kronos Bio
KRON
| – | – | -1,297,959 | Closed | -$1.07M |
|